Skip to main content
Clinical Trials/ACTRN12605000653662
ACTRN12605000653662CompletedPhase 4

Complete Tooth Loss:A Randomized Controlled Clincial Trial with Maxillary Three-Implant Overdentures Opposing Mandibular Two-Implant Overdentures.

obelBiocare Pty Ltd Australia,0 sites40 target enrollmentStarted: October 18, 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
55 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • An edentulous maxilla, and had been successfully wearing their mandibular two-implant overdenture for at least three years.

Exclusion Criteria

  • Those with Lekholm & Zarb classification16 Type E maxillae (determined radiologically), a history of smoking, a systemic disease likely to compromise implant surgery, previously bone-grafted jaws, or a history of bruxism.

Investigators

Sponsor
obelBiocare Pty Ltd Australia,

Similar Trials